Publicacions (38) Publicacions en què ha participat algun/a investigador/a

2024

  1. BZ-97: A Promising Compound Against Trypanosoma cruzi

    Current Trends in Biotechnology and Pharmacy, Vol. 18, Núm. 2, pp. 1745-1764

  2. Barriers and facilitators of health professionals in adopting digital health-related tools for medication appropriateness: A systematic review

    Digital Health, Vol. 10

  3. Bioguided Assay of Polyphenols Isolated from Medicinal Mayan Species and its Activity Against Leishmania mexicana

    Pharmacognosy Journal, Vol. 16, Núm. 1, pp. 174-180

  4. Chemical and Bioactive Properties of Red Rice with Potential Pharmaceutical Use

    Molecules, Vol. 29, Núm. 10

  5. Chronic sarpogrelate treatment improves renal sympathetic hyperactivity in experimental diabetes

    Biomedicine and Pharmacotherapy, Vol. 176

  6. Clinical and treatment outcomes of a second subcutaneous or intravenous anti-TNF in patients with ulcerative colitis treated with two consecutive anti-TNF agents: data from the ENEIDA registry

    Therapeutic Advances in Gastroenterology, Vol. 17

  7. Comparative Study of the Effectiveness of Vedolizumab Versus Ustekinumab After Anti-TNF Failure in Crohn's Disease (Versus-CD): Data from the ENEIDA Registry

    Journal of Crohn's & colitis, Vol. 18, Núm. 1, pp. 65-74

  8. Comparing AGS Beers 2019, STOPP version 2, and EU(7)-PIM list in Portuguese older adults in primary health care

    European Journal of Clinical Pharmacology, Vol. 80, Núm. 4, pp. 603-612

  9. Comparison between tofacitinib and ustekinumab as a third-line therapy in refractory ulcerative colitis: A multicenter international study

    United European Gastroenterology Journal

  10. Constrained numerical deconvolution using orthogonal polynomials

    Heliyon, Vol. 10, Núm. 3

  11. Current drug strategies for the treatment and control of schistosomiasis

    Expert Opinion on Pharmacotherapy, Vol. 25, Núm. 4, pp. 409-420

  12. Cytotoxic Cyclolignans Obtained by the Enlargement of the Cyclolignan Skeleton of Podophyllic Aldehyde, a Selective Podophyllotoxin-Derived Cyclolignan

    Molecules, Vol. 29, Núm. 7

  13. Digital Twin of Calais Canal with Model Predictive Controller: A Simulation on a Real Database

    Journal of Water Resources Planning and Management, Vol. 150, Núm. 5

  14. Discrepancies in Electronic Medical Prescriptions Found in a Hospital Emergency Department: A Prospective Observational Study

    Pharmaceuticals, Vol. 17, Núm. 4

  15. Effect of uric acid reduction on chronic kidney disease. Systematic review and meta-analysis

    Frontiers in Pharmacology, Vol. 15

  16. Effectiveness and safety of a third-line rescue treatment for acute severe ulcerative colitis refractory to infliximab or ciclosporin (REASUC study)

    Alimentary Pharmacology and Therapeutics, Vol. 59, Núm. 10, pp. 1248-1259

  17. Experimental structure based drug design (SBDD) applications for anti-leishmanial drugs: A paradigm shift?

    Medicinal Research Reviews, Vol. 44, Núm. 3, pp. 1055-1120

  18. Increased prevalence of migraine in women with inflammatory bowel disease: A cross-sectional study

    Cephalalgia : an international journal of headache, Vol. 44, Núm. 3

  19. Insights into the Neuroprotective Potential of Epicatechin: Effects against Aβ-Induced Toxicity in Caenorhabditis elegans

    Antioxidants, Vol. 13, Núm. 1

  20. Insights into the phenolic composition and in vitro bioactivity of cardoon capitulum: A nutraceutical-oriented valorization study

    Food Chemistry, Vol. 435